Nannan Chang
Senior Investment Manager @ Kaitai Capital
Nannan Chang is a Series A investor at Kaitai Capital focused on Health Care and Biotechnology. Nannan Chang
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Nannan Chang invests in
Stages Nannan Chang invests in
Countries Nannan Chang invests in
Investment Focus
Industry
- Health Care 2 (50%)
- Biotechnology 2 (50%)
- Biopharma 1 (25%)
- Therapeutics 1 (25%)
- Manufacturing 1 (25%)
Stage
- Series A 1 (25%)
- Series B 1 (25%)
- Series C 1 (25%)
Country
- China 2 (50%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PackGene Biotech
|
PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, wedeliver cost-effective, dependable, and scalable production solutions. | Series C / Apr 07, 2021 | |
Juncell Therapeutics
|
Juncell Therapeutics develops innovative therapies and pharmaceutical drugs for tumor and related treatment. | Series A / Feb 26, 2021 | |
Exegenesis Bio
|
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development. | Series B / Feb 02, 2021 | |
|
Exegenesis Bio
|
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development. | Series B / Aug 03, 2020 |
Co-Investors
About Kaitai Capital
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.
Kaitai Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Huang Zehua
Partner
|
|||
|
Jin Qi
Managing Partner
|
|||
|
Li Xianxian
Managing Partner
|
|||
|
Nannan Chang
Senior Investment Manager
|
|||
Xian Li
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Nannan Chang invest in?
Nannan Chang invests primarily in Health Care, Biotechnology and Biopharma startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nannan Chang last invest?
The most recent investment recorded for Nannan Chang closed in Apr 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
